Skip to main content
BIONEERCORPORATION logo

BIONEERCORPORATION — Investor Relations & Filings

Ticker · 064550 ISIN · KR7064550007 KO Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2022-03-11 Proxy Solicitation & In…
Country KR South Korea
Listing KO 064550

About BIONEERCORPORATION

https://eng.bioneer.com/

Bioneer Corporation is a biotechnology company that develops and manufactures molecular biology products, technologies, and services for the life science research and molecular diagnostics markets. The company's portfolio includes a range of instruments, such as conventional and real-time PCR systems, and patented auxiliary devices for sample preparation. Bioneer provides integrated solutions for molecular diagnostics, offering kits for various infectious diseases. Additionally, it offers custom services including oligo and gene synthesis. The company's research and development efforts also focus on siRNA technologies and drug delivery systems.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains details about the meeting, the agenda items (such as approval of financial statements and amendments to the articles of incorporation), and instructions for electronic voting. This falls under the category of Proxy Solicitation & Information Statement.
2022-03-11 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) and a subsequent amendment (정정신고) regarding the agenda items for the upcoming Annual General Meeting. It details the date, location, and specific agenda items (financial statements, director appointments, etc.) to be voted upon. This falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on meeting agenda items.
2022-03-03 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming 'Investor Relations (IR) Meeting' (기업설명회 개최). It provides details such as the date, time, location, target audience (analysts), and the purpose of the meeting (disclosing R&D progress). It is not the presentation itself, but an announcement of the event and the future availability of materials. According to the 'Menu vs Meal' rule, this is a notification of an event/report publication, which fits the 'Report Publication Announcement' (RPA) category.
2022-02-25 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Bioneer. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation or notice of meeting material provided to shareholders to inform them of the meeting and the items to be voted upon.
2022-02-24 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from Bioneer regarding a significant change in financial results (revenue or profit/loss structure exceeding 30%). It provides a summary table of financial performance (revenue, operating profit, net income) comparing the current fiscal year to the previous one, along with reasons for the variance. This is a standard preliminary earnings announcement required by the Korea Exchange (KRX) for listed companies, which falls under the 'Earnings Release' category. FY 2021
2022-02-24 Korean
기타경영사항(자율공시)(식약처, 코로나19 델타, 오미크론 구분 진단 키트 수출용 허가)
Regulatory Filings Classification · 100% confidence The document is a 'voluntary disclosure' (자율공시) from Bioneer regarding the approval of a COVID-19 diagnostic kit by the Ministry of Food and Drug Safety. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a simple announcement of a report publication. As it is a regulatory announcement regarding company operations and product approvals that does not fall into the other specific categories, it is classified as a general regulatory filing.
2022-01-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.